DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 212 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2022. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,209,864 | +39.7% | 285,028 | +22.2% | 0.00% | – |
Q2 2023 | $3,014,559 | -28.1% | 233,325 | -45.4% | 0.00% | -100.0% |
Q1 2023 | $4,193,638 | -5.6% | 427,486 | +2.4% | 0.00% | 0.0% |
Q4 2022 | $4,440,327 | -64.7% | 417,324 | -65.4% | 0.00% | -66.7% |
Q3 2022 | $12,594,000 | -37.0% | 1,206,282 | -24.0% | 0.00% | -25.0% |
Q2 2022 | $19,982,000 | -0.3% | 1,587,119 | -14.1% | 0.00% | +33.3% |
Q1 2022 | $20,033,000 | -59.8% | 1,848,009 | -47.8% | 0.00% | +50.0% |
Q4 2021 | $49,794,000 | -4.5% | 3,539,024 | +30.4% | 0.00% | -71.4% |
Q3 2021 | $52,134,000 | +219.0% | 2,713,838 | +63.6% | 0.01% | +133.3% |
Q2 2021 | $16,343,000 | -19.9% | 1,659,110 | -20.1% | 0.00% | 0.0% |
Q1 2021 | $20,409,000 | +64.9% | 2,076,152 | -25.3% | 0.00% | – |
Q4 2020 | $12,374,000 | +71.7% | 2,780,220 | +66.7% | 0.00% | -100.0% |
Q3 2020 | $7,205,000 | -47.3% | 1,667,715 | +8.2% | 0.00% | -33.3% |
Q2 2020 | $13,671,000 | +789.5% | 1,541,138 | +253.9% | 0.00% | – |
Q1 2020 | $1,537,000 | -68.8% | 435,443 | -49.4% | 0.00% | -100.0% |
Q4 2019 | $4,922,000 | +2.9% | 860,379 | -35.7% | 0.00% | 0.0% |
Q3 2019 | $4,784,000 | -53.0% | 1,338,165 | -47.5% | 0.00% | 0.0% |
Q2 2019 | $10,180,000 | +66.1% | 2,551,125 | +204.4% | 0.00% | -50.0% |
Q1 2019 | $6,127,000 | -30.9% | 838,076 | -13.5% | 0.00% | -50.0% |
Q4 2018 | $8,868,000 | -19.5% | 969,203 | +9.0% | 0.00% | 0.0% |
Q3 2018 | $11,021,000 | -30.1% | 888,827 | -14.0% | 0.00% | -33.3% |
Q2 2018 | $15,765,000 | +40.7% | 1,033,720 | +83.1% | 0.01% | +100.0% |
Q1 2018 | $11,206,000 | -39.4% | 564,508 | -43.0% | 0.00% | -50.0% |
Q4 2017 | $18,505,000 | +20.8% | 989,596 | +38.9% | 0.01% | -14.3% |
Q3 2017 | $15,313,000 | +19.4% | 712,266 | -46.4% | 0.01% | +16.7% |
Q2 2017 | $12,830,000 | +232.2% | 1,329,588 | +104.9% | 0.01% | +100.0% |
Q1 2017 | $3,862,000 | +46.3% | 648,919 | -2.9% | 0.00% | +200.0% |
Q4 2016 | $2,640,000 | -73.9% | 668,378 | -30.6% | 0.00% | -80.0% |
Q3 2016 | $10,100,000 | -26.1% | 962,800 | +2.7% | 0.01% | -37.5% |
Q2 2016 | $13,663,000 | -17.9% | 937,098 | +8.3% | 0.01% | -11.1% |
Q1 2016 | $16,647,000 | +48.2% | 865,217 | +86.1% | 0.01% | +80.0% |
Q4 2015 | $11,233,000 | +92.7% | 464,967 | +95.8% | 0.01% | +66.7% |
Q3 2015 | $5,828,000 | -7.4% | 237,474 | -11.7% | 0.00% | +50.0% |
Q2 2015 | $6,297,000 | +37.3% | 268,818 | +31.5% | 0.00% | 0.0% |
Q1 2015 | $4,587,000 | +9.8% | 204,486 | -17.4% | 0.00% | +100.0% |
Q4 2014 | $4,176,000 | – | 247,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |